内分泌科临床药师参与1例糖尿病合并高催乳素血症患者的治疗实践

王涛; 邓昂

doi:10.3969/j.issn.1006-0111.2015.02.020

内分泌科临床药师参与1例糖尿病合并高催乳素血症患者的治疗实践

doi: 10.3969/j.issn.1006-0111.2015.02.020

王涛¹,
邓昂^2,

1.
徐州医学院附属医院药学部, 江苏徐州 221006
2.
北京中日友好医院药学部, 北京 100029

Clinical practice of an endocrinology clinical pharmacists participating in the treatment of a patient with diabetes and hyperprolactinemia

WANG Tao¹,
DENG Ang^2
,

1.
Department of Pharmacy, Affiliated Hospital of Xuzhou Medical College, Xuzhou 221006, China
2.
Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China

摘要: 目的探讨内分泌科临床药师参与临床药物治疗的工作模式。方法临床药师通过参与1例糖尿病合并高催乳素血症患者的治疗,分析患者血糖控制不佳及高催乳素血症的原因,提出治疗方案。结果长期服用抗精神病药物可能是患者血糖控制不佳的原因之一。高催乳素血症可能与患者长期服用抗精神病药帕潘立酮缓释片有关,建议患者转诊精神科,选用无升高催乳素作用的抗精神病药物治疗。结论临床药师积极参与临床治疗,能有效提高患者用药的合理性和依从性。
- 临床药师 /
- 糖尿病 /
- 高催乳素血症 /
- 抗精神病药物
Abstract: Objective To explore the working pattern for endocrinology clinical pharmacists participating in clinical drug treatment. Methods By participating in the treatment for a patient with diabetes and hyperprolactinemia and analyzing the causes of poor glycemic control and hyperprolactinemia, clinical pharmacists proposed therapeutic regimen. Results The long-term psychotropic medication may be one of the reasons why blood glucose of the patient was unsatisfactorily controlled. The patient with hyperprolactinemia may be associated with her longstanding use of paliperidone. The patient was recommended to consult a psychiatrist and switch to an alternative medication which does not cause hyperprolactinemia. Conclusion The active participation of clinical pharmacists during clinical drug therapy could improve the medication rationality and compliance of patients with drugs.
- clinical pharmacist /
- diabetes /
- hyperprolactinemia /
- antipsychotic drug

[1]	黎燕, 罗维肖. 非典型抗精神病药与糖尿病关系的研究[J]. 临床精神医学杂志, 2002, 12(5):299-300.
[2]	林琳, 瞿发林. 抗精神病药所致高催乳素血症的防治进展[J]. 实用药物与临床, 2010, 13(4):290-292.
[3]	牟晓东, 张志. 抗精神病药物治疗与血糖调节紊乱[J]. 国外医学精神病学分册, 2004, 31(2):86-88.
[4]	娄素琴, 杨广声, 钱东丽. 抗精神病药物引起血糖升高135例[J]. 医药导报, 2006, 25(10):1009.
[5]	Holt RI, Peveler RC. Association between antipsychotic drugs and diabetes[J]. Diabetes Obes Metab, 2006, 8(2):125-135.
[6]	Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature[J]. J Clin Psychiatr, 2001, 62 (Suppl 7): 22-31.
[7]	Lu CH, Yan YH. Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient[J]. Diabetes Res Clin Pract, 2009, 83(2):e66-67.
[8]	Bostwick JR, Guthrie SK, Ellingrod VL. Antipsychotic-induced hyperprolactinemia[J]. Pharmacotherapy, 2009, 29(1) :64-73.
[9]	Kapur S, Langlois X, Vinken P, et al. The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats[J]. J Pharmacol Exp Ther, 2002, 302(3):1129-1134.
[10]	Staller J. The effect of long-term antipsychotic treatment on prolactin[J]. J Child Adolesc Psychopharmacol, 2006, 16(3):317-326.
[11]	Knegtering R, Baselmans P, Castelein S, et al. Predominant role of the 9-Hydroxy metabolite of risperidone in elevating blood prolactin levels[J]. Am J Psychiatr, 2005, 162(5):1010-1012.
[12]	Melkersson KI. Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite[J]. Hum Psychopharmacol, 2006, 21(8): 529-532.
[13]	Citrome L. Paliperidone: quo vadis?[J]. Int J Clin Pract, 2007, 61(4):653-662.
[14]	Meltzer HY, Bobo WV, Nuamah IF, et al. Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies[J]. J Clin Psychiatr, 2008, 69(5): 817-829.
[15]	Einarson TR,Hemels ME,Nuamah I,et al.An analysis of potentially prolactin-related adverse events and abnormal prolactin values in randomized clinical trials with paliperidone palmitate[J].Ann Pharmacother,2012,46(10):1322-1330.
[16]	Molitch ME. Drugs and prolactin[J]. Pituitary, 2008, 11(2): 209-218.
[17]	Bankowski BJ, Zacur HA. Dopamine agonist therapy for hyperprolactinemia[J]. Clin Obstet Gynecol, 2003, 46 (2):349-362.
[18]	郭金宏,曹长安. 溴隐亭治疗抗精神病药物致高泌乳素血症的临床研究[J]. 神经疾病与精神卫生, 2003, 3(3) : 244.
[19]	Lee MS, Song HC, An H, et al. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study[J]. Psychiatr Clin Neurosci, 2010, 64(1):19-27.
[20]	Rocha FL, Hara C, Ramos MG. Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia[J]. Prog Neuropsychopharmacol Biol Psychiatr, 2010, 34(6):1153-1154.
[21]	魏桂林, 徐小薇, 李大魁. 药物与高催乳素血症[J]. 药物不良反应杂志, 2000, 2(2):73-75.

[1]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[2]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[3]	夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞. 核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
[4]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[5]	陈怡君, 王卓, 何苗, 张宇, 田泾. 泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
[6]	张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一. 药物性肝损伤不良反应分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404034
[7]	张元林, 宋凯, 孙蕊, 舒飞, 舒丽芯, 杨樟卫. 基于真实世界数据的药物利用研究综述 . 药学实践与服务, 2024, 42(6): 238-243. doi: 10.12206/j.issn.2097-2024.202312010
[8]	黄韵, 张正银, 金英, 郑怡菁, 李铁军, 孙莉莉. 耐碳青霉烯类肺炎克雷伯菌及大肠埃希菌临床分离株耐药性及耐药基因分析 . 药学实践与服务, 2024, 42(10): 439-444. doi: 10.12206/j.issn.2097-2024.202309059
[9]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘患者的临床疗效观察 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202405035
[10]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[11]	杨凤艳, 张月, 陈恩贤, 缪雪蓉, 魏凯. 瑞马唑仑临床应用研究进展 . 药学实践与服务, 2024, 42(9): 365-374. doi: 10.12206/j.issn.2097-2024.202405026
[12]	温瑞睿, 许龙, 朱文静, 杨建伟. 浅谈国外药师主导开展戒烟服务的作用与挑战 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202408054
[13]	徐璐璐, 刘爱军. 丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2024, 42(12): 1-8. doi: 10.12206/j.issn.2097-2024.202312027
[14]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202401050
[15]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 479-486. doi: 10.12206/j.issn.2097-2024.202401073
[16]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[17]	刘依秦, 王超群, 邱娇娜. 胆宁片预处理在糖尿病患者结肠镜检查前的应用效果分析 . 药学实践与服务, 2024, 42(9): 407-410. doi: 10.12206/j.issn.2097-2024.202407037
[18]	崔晓林, 付晓菲, 杜艳红, 刘娟, 朱茜, 刘子祺. 临床药师参与吉瑞替尼致QTc间期延长的病例分析 . 药学实践与服务, 2024, 42(6): 263-266. doi: 10.12206/j.issn.2097-2024.202309050
[19]	徐飞, 陈瑾, 鲁育含, 李志勇. 肠道菌群参与糖尿病肾病的机制研究进展 . 药学实践与服务, 2024, 42(5): 181-184, 197. doi: 10.12206/j.issn.2097-2024.202312023

点击查看大图

计量

文章访问数: 2589
HTML全文浏览量: 284
PDF下载量: 421
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

内分泌科临床药师参与1例糖尿病合并高催乳素血症患者的治疗实践

doi: 10.3969/j.issn.1006-0111.2015.02.020

Clinical practice of an endocrinology clinical pharmacists participating in the treatment of a patient with diabetes and hyperprolactinemia

计量

内分泌科临床药师参与1例糖尿病合并高催乳素血症患者的治疗实践

doi: 10.3969/j.issn.1006-0111.2015.02.020

1. 徐州医学院附属医院药学部, 江苏徐州 221006

2. 北京中日友好医院药学部, 北京 100029

English Abstract

Clinical practice of an endocrinology clinical pharmacists participating in the treatment of a patient with diabetes and hyperprolactinemia

1. Department of Pharmacy, Affiliated Hospital of Xuzhou Medical College, Xuzhou 221006, China

2. Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China

全文HTML

目录

留言板

内分泌科临床药师参与1例糖尿病合并高催乳素血症患者的治疗实践

doi: 10.3969/j.issn.1006-0111.2015.02.020

Clinical practice of an endocrinology clinical pharmacists participating in the treatment of a patient with diabetes and hyperprolactinemia

计量

出版历程

内分泌科临床药师参与1例糖尿病合并高催乳素血症患者的治疗实践

doi: 10.3969/j.issn.1006-0111.2015.02.020

1. 徐州医学院附属医院药学部, 江苏 徐州 221006 2. 北京中日友好医院药学部, 北京 100029

English Abstract

Clinical practice of an endocrinology clinical pharmacists participating in the treatment of a patient with diabetes and hyperprolactinemia

1. Department of Pharmacy, Affiliated Hospital of Xuzhou Medical College, Xuzhou 221006, China 2. Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China

全文HTML

目录

1. 徐州医学院附属医院药学部, 江苏徐州 221006

2. 北京中日友好医院药学部, 北京 100029

1. Department of Pharmacy, Affiliated Hospital of Xuzhou Medical College, Xuzhou 221006, China

2. Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China